Miracle surgery saves man with rare brain bubble at NYU Langone

Ivor Parker and Karen Palaza have been together for 20 years and treat each day as if it were Valentine’s Day.

Intas to pay €42M upfront in Henlius deal; Kymera gets $40M milestone; Pluvicto no longer in short supply

Plus, news from Vicore, Elevate Bio, Monte Rosa Therapeutics and Angitia: Intas, Henlius ink another deal: Intas said Friday it plans to pay €42 million

October 28, 2023

Gene editing has had a big week in the spotlight. Here’s what’s going on

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here

November 1, 2023

A new startup wants to fight cancer with ‘off-the-shelf’ gene therapy, securing $26M seed round

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.